Literature DB >> 17994346

Phase advance is an actimetric correlate of antidepressant response to sleep deprivation and light therapy in bipolar depression.

Francesco Benedetti1, Sara Dallaspezia, Mara Cigala Fulgosi, Barbara Barbini, Cristina Colombo, Enrico Smeraldi.   

Abstract

The combination of total sleep deprivation (TSD) and light therapy (LT) in bipolar depression causes rapid antidepressant effects, and its mechanism of action has been hypothesized to involve the enhancement of all of the monoaminergic systems targeted by antidepressant drugs (serotonin, dopamine, norepinephrine). It is still unknown if the clinical effects are paralleled by changes in biological rhythms. In a before/after design of a study of biological correlates of response, 39 inpatients affected by Type I Bipolar Disorder whose current depressive episode was without psychotic features were treated for one week with repeated TSD combined with morning LT. Wrist actigraphy was recorded throughout the study. Two-thirds of the patients responded to treatment (50% reduction in Hamilton Depression score). Responders showed an increase in daytime activity, phase-advance of the activity-rest rhythm of 57 min compared to the pre-treatment baseline, and reduced nighttime sleep. Non-responders did not show significant changes in the parameters of their activity-rest rhythm. Phase advance of the activity-rest rhythm is an actimetric correlate of the antidepressant response to TSD and LT in bipolar depression. Results are consistent with the known effects of sleep-wake manipulations and neurotransmitter function on the suprachiasmatic nucleus.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17994346     DOI: 10.1080/07420520701649455

Source DB:  PubMed          Journal:  Chronobiol Int        ISSN: 0742-0528            Impact factor:   2.877


  25 in total

Review 1.  Chronobiological Therapy for Mood Disorders.

Authors:  Sara Dallaspezia; Masahiro Suzuki; Francesco Benedetti
Journal:  Curr Psychiatry Rep       Date:  2015-12       Impact factor: 5.285

2.  Ketamine-Induced Glutamatergic Mechanisms of Sleep and Wakefulness: Insights for Developing Novel Treatments for Disturbed Sleep and Mood.

Authors:  Wallace C Duncan; Elizabeth D Ballard; Carlos A Zarate
Journal:  Handb Exp Pharmacol       Date:  2019

3.  Evaluating sleep in bipolar disorder: comparison between actigraphy, polysomnography, and sleep diary.

Authors:  Katherine A Kaplan; Lisa S Talbot; June Gruber; Allison G Harvey
Journal:  Bipolar Disord       Date:  2012-12       Impact factor: 6.744

4.  The longitudinal course of sleep timing and circadian preferences in adults with bipolar disorder.

Authors:  Mohammad A Seleem; John A Merranko; Tina R Goldstein; Benjamin I Goldstein; David A Axelson; David A Brent; Vishwajit L Nimgaonkar; Rasim S Diler; Dara J Sakolsky; David J Kupfer; Boris Birmaher
Journal:  Bipolar Disord       Date:  2014-12-19       Impact factor: 6.744

5.  Bright light therapy in the treatment of patients with bipolar disorder: A systematic review and meta-analysis.

Authors:  Shengjun Wang; Zhigang Zhang; Li Yao; Nannan Ding; Lingjie Jiang; Yuchen Wu
Journal:  PLoS One       Date:  2020-05-21       Impact factor: 3.240

Review 6.  Clocking in: chronobiology in rheumatoid arthritis.

Authors:  Frank Buttgereit; Josef S Smolen; Andrew N Coogan; Christian Cajochen
Journal:  Nat Rev Rheumatol       Date:  2015-03-24       Impact factor: 20.543

7.  Motor-Activity Markers of Circadian Timekeeping Are Related to Ketamine's Rapid Antidepressant Properties.

Authors:  Wallace C Duncan; Elizabeth Slonena; Nadia S Hejazi; Nancy Brutsche; Kevin C Yu; Lawrence Park; Elizabeth D Ballard; Carlos A Zarate
Journal:  Biol Psychiatry       Date:  2017-03-28       Impact factor: 13.382

8.  Detecting change in biological rhythms: a multivariate permutation test approach to Fourier-transformed data.

Authors:  Jennifer Urbano Blackford; Ronald M Salomon; Niels G Waller
Journal:  Chronobiol Int       Date:  2009-02       Impact factor: 2.877

Review 9.  Ambulatory assessment.

Authors:  Timothy J Trull; Ulrich Ebner-Priemer
Journal:  Annu Rev Clin Psychol       Date:  2012-11-13       Impact factor: 18.561

10.  Selective serotonin reuptake inhibitors and raft inhibitors shorten the period of Period1-driven circadian bioluminescence rhythms in rat-1 fibroblasts.

Authors:  Kazumi Nomura; Oscar Castanon-Cervantes; Alec Davidson; Chiaki Fukuhara
Journal:  Life Sci       Date:  2008-04-16       Impact factor: 5.037

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.